Malignant melanoma--clinical development of peptide-based melanoma vaccines.
Schmittel
Alexander
A
Medizinische Klinik III, Hematology, Oncology, and Transfusion Medicine, Charité, Campus Benjamin Franklin, Berlin, Germany.
Scheibenbogen
Carmen
C
Letsch
Anne
A
Asemissen
Anne-Marie
AM
Thiel
Eckhard
E
Keilholz
Ulrich
U
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D006801:Humans; D008545:Melanoma / Q000517:prevention & control*; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins / Q000276:immunology*; D010446:Peptide Fragments / Q000276:immunology*; D012878:Skin Neoplasms / Q000517:prevention & control*
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins; D010446:Peptide Fragments